Therapeutic Goods Amendment (2018 Measures No. 1) Bill 2018
Became law
| Act | Therapeutic Goods Amendment (2018 Measures No. 1) Act 2018 |
|---|---|
| Number | No. 104, 2018 |
| Assent | 21 Sep 2018 |
| Status | In force |
Sourced from the Federal Register of Legislation at 21 Nov 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.
Progress
| Date | Step |
|---|---|
| House | |
| 28 Jun 2018 | Introduced and read a first time |
| 28 Jun 2018 | Second reading moved |
| 16 Aug 2018 | Second reading debate |
| 20 Aug 2018 | Second reading debate |
| 20 Aug 2018 | Second reading agreed to |
| 20 Aug 2018 | Third reading agreed to |
| Senate | |
| 20 Aug 2018 | Introduced and read a first time |
| 20 Aug 2018 | Second reading moved |
| 10 Sep 2018 | Second reading debate |
| 10 Sep 2018 | Second reading agreed to |
| 10 Sep 2018 | Third reading agreed to |
| 10 Sep 2018 | Finally passed both Houses |
| 21 Sep 2018 | Assent |
Amends the Therapeutic Goods Act 1989 to:
- introduce mandatory reporting requirements for sponsors of mainly prescription medicines to report shortages of, and any decision to permanently discontinue, their products
- make miscellaneous amendments in relation to: enabling standards to adopt other documents as in force from time to time
- enabling the Secretary to require priority pathway applicants to provide supporting information
- streamlining of health practitioner notifications under the Special Access Scheme and certain advertising requirements
- variations to registered medicines through notification
- a minor technical amendment.
Summary from the official bill homepage.
Documents
Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.